BioInno

Beijing, China · Founded 2019 · Privately Held (backing)

Provider of CDMO process development and GMP production services for cell culture, bioprocessing, and biologics-related technical applications. BioInno is based in Beijing, China and was founded in 2019. Its last reported valuation was $156 million in Dec 2021. It has raised $48.1 million.

Last reported valuation

$156.4M

Oct 2026

Priced at

—

Total raised

$48.1M

Last round

—

How much has BioInno raised?

$48.1Macross 0 recorded rounds

Free account

More of BioInno with a free account

·The complete investor list: 13 names
·Watch BioInno: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

BioInno investors

13 investors are on record for BioInno, including Shenzhen Yifeng Investment Management Enterprise, Tailong VC, Orient Securities Capital Investment Company and Ciit Asset Management.

For fundraisers

Raising for a company like BioInno?

13 investors have backed BioInno.

See all 13 investors →

Frequently asked about BioInno

How much has BioInno raised?: BioInno has raised $48.1M in total across 0 recorded funding rounds.